Hostname: page-component-6bf8c574d5-k2jvg Total loading time: 0 Render date: 2025-03-07T03:30:25.051Z Has data issue: false hasContentIssue false
  • English
  • Français

The impact of a comprehensive coronavirus disease 2019 (COVID-19) infection prevention bundle on non–COVID-19 hospital-acquired respiratory viral infection (HA-RVI) rates

Published online by Cambridge University Press:  02 June 2022

Jessica L. Seidelman Open the ORCID record for Jessica L. Seidelman [Opens in a new window] ,
Lauren DiBiase ,
Ibukunoluwa C. Kalu Open the ORCID record for Ibukunoluwa C. Kalu [Opens in a new window] ,
Sarah S. Lewis ,
Emily Sickbert-Bennett ,
David J. Weber Open the ORCID record for David J. Weber [Opens in a new window]  and
Becky A. Smith
Jessica L. Seidelman*
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Duke University, Durham, North Carolina
Lauren DiBiase
Affiliation:
Department of Hospital Epidemiology, University of North Carolina Hospitals, Chapel Hill, North Carolina Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina
Ibukunoluwa C. Kalu
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina Department of Pediatrics, Division of Pediatric Infectious Diseases, Pediatric Infection Prevention, Duke University Medical Center, Durham, North Carolina
Sarah S. Lewis
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Duke University, Durham, North Carolina
Emily Sickbert-Bennett
Affiliation:
Department of Hospital Epidemiology, University of North Carolina Hospitals, Chapel Hill, North Carolina Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina
David J. Weber
Affiliation:
Department of Hospital Epidemiology, University of North Carolina Hospitals, Chapel Hill, North Carolina Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina
Becky A. Smith
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Duke University, Durham, North Carolina
*
Author for correspondence: Jessica L. Seidelman, E-mail jessica.seidelman@duke.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

After implementing a coronavirus disease 2019 (COVID-19) infection prevention bundle, the incidence rate ratio (IRR) of non–severe acute respiratory coronavirus virus 2 (non–SARS-CoV-2) hospital-acquired respiratory viral infection (HA-RVI) was significantly lower than the IRR from the pre–COVID-19 period (IRR, 0.322; 95% CI, 0.266–0.393; P < .01). However, HA-RVIs incidence rates mirrored community RVI trends, suggesting that hospital interventions alone did not significantly affect HA-RVI incidence.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 6 , June 2023 , pp. 1022 - 1024
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. Preliminary data from this study were presented as a poster presentation at the SHEA 2021 Spring Conference on April 7, 2021, held virtually. Abstract #96.

References

Olsen, SJ, Winn, AK, Budd, AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021. Morb Mortal Wkly Rep 2021;70:1013–1019.CrossRefGoogle Scholar
Haddadin, Z, Schuster, JE, Spieker, AJ, et al. Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: prospective multicenter study. Pediatrics 2021;148:e2021051462.CrossRefGoogle ScholarPubMed
Hidron, AI, Edwards, JR, Patel, J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008;29:996–1011.CrossRefGoogle Scholar
Lessler, J, Reich, NG, Brookmeyer, R, Perl, TM, Nelson, KE, Cummings, DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis May 2009;9:291–300.CrossRefGoogle ScholarPubMed
Tanner, J, Dumville, JC, Norman, G, Fortnam, M. Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev 2016;CD004288.Google ScholarPubMed
Seidelman, JL, Lewis, SS, Advani, SD, et al. Universal masking is an effective strategy to flatten the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) healthcare worker epidemiologic curve. Infect Control Hosp Epidemiol 2020;41:1466–1467.CrossRefGoogle ScholarPubMed
Daniels, S, Wei, H, Han, Y, et al. Risk factors associated with respiratory infectious disease-related presenteeism: a rapid review. BMC Public Health 2021;21:1955.CrossRefGoogle ScholarPubMed
Gur-Arie, R, Katz, MA, Hirsch, A, et al. “You have to die not to come to work”: a mixed methods study of attitudes and behaviors regarding presenteeism, absenteeism and influenza vaccination among healthcare personnel with respiratory illness in Israel, 2016–2019. Vaccine 2021;39:2366–2374.CrossRefGoogle ScholarPubMed